Ayurvedic treatment of childhood bronchial asthma

A clinical study of haridradi avaleha in the management of tamaka shwasa with special reference to childhood bronchial asthma

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/023055

Enrollment

Registered

2020-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Haridradi Avaleha: Dosage (Age group 5 TO 8 Years)- 20gms,(Age group 9 To 12 Years)-30gms,(Age group 13 To 16 Years)-45gms two times per day before food Route of Administration-Oral Du

Eligibility

Inclusion criteria

Inclusion criteria: 1 subject with age group 5 to 16 Years will be included in the study irrespective of sex , Caste & religion. PEFR >60% of personal best Intermittent, Mild persistent, Moderate persistent cases of childhood bronchial asthma.

Exclusion criteria

Exclusion criteria: Age below 5 and more than 16 Years. PEFR Severe persistent cases of asthma. Patients taking oral or inhaled steriods on regular basis.

Design outcomes

Primary

Measure	Time frame
frequency of shwasa vegas, wheezing, kapha, night symptoms, relief in sitting posture etc symptoms will be reliefedTimepoint: 15thday, 30th day, 45th day, 60th day	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr Aboli Patil

Parul Institute of Ayurved

drabolipatil@gmail.com9422783313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026